Abstract:
Glucocorticoid hormones (cortisol in humans and corticosterone in rodents) are secreted in discrete pulses during a day with a periodicityof approximately 1 h (ultradian rhythm), and this pattern is also maintained in plasma and extracellular fluid. However, the vast majority of studies on gene regulation by glucocorticoids typically assess gene responses regardless the ultradian rhythm. These experiments are usually performed using long-term stimulation with synthetic hormones (dexamethasone and triamcinolone), which form much more stable complexes with glucocorticoid receptor (GR) then natural hormones. This review summarizes the current scarce information, obtained in experiments mimicking the ultradian mode of natural hormone secretion in cultured cells and in animal models.
The results of these experiments clearly demonstrate that ultradian stimulation by natural hormones induces rapid GR exchange with glucocorticoid response elements and leads to cyclic GR mediated transcriptional regulation (gene pulsing) at the level of nascent RNA. In contrast, synthetic glucocorticoids, having much higher receptor affinity, fail to disengage from nuclear receptors with sufficient speed to support the ultradian cycles, thereby uncoupling extracellular hormone fluctuations from appropriate receptor function at response elements. This alters RNA accumulation profiles dramatically. These findings suggest potentially important consequences of ultradian secretion. The transcriptional program induced by hormone pulses differs significantly from that generated by constant hormone treatment. Thus, treatment with synthetic glucocorticoids may not provide an accurate assessment of physiological hormone action.
About The Authors:
V. M. Merkulov. Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, Russian Federation
T. I. Merkulova. Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia Novosibirsk State University, Novosibirsk, Russia, Russian Federation
References:
1. Agbemafle B.M, Oesterreicher T.J., Shaw C.A., Henning S.J. Immediate early genes of glucocorticoid action on the developing intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2005;288:G897-G906. DOI:10.1152/ajpgi.00454.2004
2. Baiula M., Spampinato S. Mapracorat, a novel non-steroidal selective glucocorticoid receptor agonist for the treatment of allergic conjunctivitis. Inflamm. Allergy Drug Targets. 2014;13(5):289-298. DOI:10.2174/1871528113666141106101356
3. Barbetta L., Dall’Asta C., Re T., Libè R., Costa E., Ambrosi B. Comparison of different regimes of glucocorticoid replacement therapy in patients with hypoadrenalism. J. Endocrinol. Invest. 2005;28(7): 632-637.
4. Bareille P., Hardes K., Donald A.C. Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial. J. Asthma. 2013;50(10):1077-1082. DOI: 10.3109/02770903.2013.837480
5. Belvisi M.G., Wicks S.L., Battram C.H., Bottoms S.E., Redford J.E., Woodman P., Brown T.J., Webber S.E., Foster M.L. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J. Immunol. 2001;166(3):1975-1982. DOI:10.4049/jimmunol.166.3.1975
6. Catley M. Dissociated steroids. Sci. World J. 2007;7:421-430. DOI: 10.1100/tsw.2007.97
7. Chrousos G.P., Charmandari E., Kino T. Glucocorticoid action networks — an introduction to systems biology. J. Clin. Endocrinol. Metab. 2004;89:563-564. DOI: 10.1210/jc.2003-032026
8. Conway-Campbell B.L., Sarabdjitsingh R.A., McKenna M.A., Pooley J.R., Kershaw Y.M., Meijer O.C., De Kloet E.R., Lightman S.L. Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. J. Neuroendocrinol. 2010;22(10):1093-100. DOI: 10.1111/j.1365-2826.2010.02051.x
9. Conway-Campbell B.L., Pooley J.R., Hager G.L., Lightman S.L. Molecular dynamics of ultradian glucocorticoid receptor action. Mol. Cell Endocrinol. 2012;348(2):383-393. DOI: 10.1016/j.mce.2011.08.014
10. Droste S.K., de Groote L., Atkinson H.C., Lightman S.L., Reul J.M., Linthorst A.C. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology. 2008;149(7):3244-53. DOI: 10.1210/en.2008-0103
11. Gross K.L, Cidlowski J.A. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol. Metab. 2008;19:331-339. DOI: 10.1016/j.tem.2008.07.009
12. Gupta V., Galante A., Soteropoulos P., Guo S., Wagner B.J. Global gene profiling reveals novel glucocorticoid induced changes in gene expression of human lens epithelial cells. Mol. Vis. 2005;11:1018-1040.
13. Gustafsson J.A. Steroids and scientist. Mol. Endocrinol. 2005;19: 61412-61417. DOI: 10.1210/me.2004-0479
14. Hardin P.E, Hall J.C., Rosbash M. Circadian oscillations in period gene mRNA levels are transcriptionally regulated. Proc. Natl Acad. Sci. USA. 1992;89(24):11711-11715.
15. Hartmann A., Veldhuis J.D., Deuschle M., Standhardt H., Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging. 1997;18(3):285-289. DOI: 10.1016/S0197-4580(97)80309-0
16. Henley D.E., Russell G.M., Douthwaite J.A., Wood S.A., Buchanan F., Gibson R., Woltersdorf W.W., Catterall J.R., Lightman S.L. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J. Clin. Endocrinol. Metab. 2009;94(11):4234-4342. DOI: 10.1210/jc.2009-1174
17. Henley D.E., Lightman S.L. Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signaling. Clin. Endocrinol. (Oxf). 2014;80(5):621-628. DOI: 10.1111/cen.12422
18. Hierholzer K., Buhler H. Metabolism of cortical steroid hormones and their general mode of action. Comprehensive human physiology. Ed. R. Greger, U. Windhorst. Berlin, Heidelberg: Springer-Verlag, 1996.
19. Himes B.E., Jiang X., Wagner P., Hu R., Wang Q., Klanderman B., Whitaker R.M., Duan Q., Lasky-Su J., Nikolos C., Jester W., Johnson M., Panettieri R.A. Jr., Tantisira K.G., Weiss S.T., Lu Q. RNASeq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells. PLoS One. 2014;9(6):e99625. DOI: 10.1371/journal.pone.0099625
20. Johannsson G., Nilsson A.G., Bergthorsdottir R., Burman P., Dahlqvist P., Ekman B., Engström B.E., Olsson T., Ragnarsson O., Ryberg M., Wahlberg J., Biller B.M., Monson J.P., Stewart P.M., Lennernäs H., Skrtic S. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J. Clin. Endocrinol. Metab. 2012;97(2):473-481. DOI: 10.1210/jc.2011-1926
21. John S., Johnson T.A., Sung M.H., Biddie S.C., Trump S., Koch-Paiz C.A., Davis S.R., Walker R., Meltzer P.S., Hager G.L. Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology. 2009;150(4):1766-1774. DOI: 10.1210/en.2008-0863
22. Kino T., Nordeen S.K., Chrousos G.P. Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300. J. Steroid Biochem. Mol. Biol. 1999;70(1/3):15-25. DOI:10.1016/S0960-0760(99)00100-4
23. Lightman S.L. Patterns of exposure to glucocorticoid receptor ligand. Biochem. Soc. Trans. 2006;34(6):1117-1118. DOI: 10.1042/BST0341117
24. Lightman S.L., Wiles C.C., Atkinson H.C., Henley D.E., Russell G.M., Leendertz J.A., McKenna M.A., Spiga F., Wood S.A., Conway-Campbell B.L. The significance of glucocorticoid pulsatility. Eur. J. Pharmacol. 2008;583(2/3):255-262. DOI: 10.1016/j.ejphar.2007.11.073
25. Löwenberg M., Stahn C., Hommes D.W., Buttgereit F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids. 2008;73(9/10):10251029. DOI:10.1016/j.steroids.2007.12.002
26. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835-839. DOI: 10.1016/0092-8674(95)90199-X
27. Merkulov V.M., Merkulova T.I. Structural variants of glucocorticoid receptor binding sites and different versions of positive glucocorticoid responsive elements: Analysis of GR-TRRD database. J. Steroid Biochem. Mol. Biol. 2009;115:1-8. DOI: 10.1016/j.jsbmb.2009.02.003
28. Miner J.N., Hong M.H., Negro-Vilar A. New and improved glucocorticoid receptor ligands. Expert Opin. Investig. Drugs. 2005;14(12): 1527-1545. DOI: 10.1517/13543784.14.12.1527
29. Morris C.J., Aeschbach D., Scheer F.A. Circadian system, sleep and endocrinology. Mol. Cell. Endocrinol. 2012;349:91-104. DOI: 10.1016/j.mce.2011.09.003
30. Nishi M., Kawata M. Brain corticosteroid receptor dynamics and trafficking: Implications from live cell imaging. Neuroscientist. 2006;12(2):119-133.
31. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissuespecific actions of glucocorticoids. J. Biol. Chem. 2011;286:31773184. DOI:10.1074/jbc.R110.179325
32. Oakley R.H., Cidlowski J.A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 2013;132(5):1033-1044. DOI: 10.1016/j.jaci.2013.09.007
33. Payvar F., Wrange O., Carlstedt-Duke J., Okret S., Gustafsson J.A., Yamamoto K.R. Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc. Natl Acad. Sci. USA. 1981;78(11):6628-6632.
34. Phuc Le P., Friedman J.R., Schug J., Brestelli J.E., Parker J.B., Bochkis I.M., Kaestner K.H. Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet. 2005;1(2):e16. DOI:10.1371/journal.pgen.0010016
35. Planey S.L., Abrams M.T., Robertson N.M., Litwack G. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res. 2003;63:172-178.
36. Pratt W.B., Galigniana M.D., Morishima Y., Murphy P.J. Role of molecular chaperones in steroid receptor action. Essays Biochem. 2004;40:41-58.
37. Qian X., Droste S.K., Lightman S.L., Reul J.M., Linthorst A.C. Circadian and ultradian rhythms of free glucocorticoid hormone are highly synchronized between the blood, the subcutaneous tissue, and the brain. Endocrinology. 2012;153(9):4346-4353. DOI: 10.1210/en.2012-1484
38. Reddy T.E., Pauli F., Sprouse R.O., Neff N.F., Newberry K.M., Garabedian M.J., Myers R.M. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 2009;19(12):2163-2171. DOI: 10.1101/gr.097022.109
39. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids — new mechanisms for old drugs. N. Engl. J. Med. 2005;353(16):17111723. DOI: 10.1056/NEJMra050541
40. Russell G.M., Lightman S.L. Can side effects of steroid treatments be minimized by the temporal aspects of delivery method? Expert Opin. Drug Saf. 2014;13(11):1501-1513. DOI: 10.1517/14740338.2014.965141
41. Saksida T., Vujicic M., Nikolic I., Stojanovic I., Haegeman G., StosicGrujicic S. Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice. Br. J. Pharmacol. 2014;171(24):58985909. DOI: 10.1111/bph.12892
42. Schoneveld O.J., Gaemers I.C., Lamers W.H. Mechanisms of glucocorticoid signaling. Biochem. Biophys. Acta. 2004;1680(2):114-128.
43. Seale J.V., Wood S.A., Atkinson H.C., Bate E., Lightman S.L., Ingram C.D., Jessop D.S., Harbuz M.S. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J. Neuroendocrinol. 2004;16(6):516-524. DOI: 10.1111/j.1365-2826.2004.01195.x
44. Simons S.S.Jr. Glucocorticoid receptor cofactors as therapeutic targets. Curr. Opin. Pharmacol. 2010;10:613-619. DOI: 10.1016/j.coph.2010.08.001
45. Skuza G., Szymańska M., Budziszewska B., Abate C., Berardi F. Effects of PB190 and PB212, new σ receptor ligands, on glucocorticoid receptor-mediated gene transcription in LMCAT cells. Pharmacol. Rep. 2011;63(6):1564-1568.
46. Stahn C., Löwenberg M., Hommes D.W., Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell Endocrinol. 2007;275(1/2):71-78. DOI:10.1016/j.mce.2007.05.019
47. So A.Y., Chaivorapol C., Bolton E.C., Li H., Yamamoto K.R. Determinants of celland gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 2007;3:e94. DOI:10.1371/journal.pgen.0030094
48. Stavreva D.A., Wiench M., John S., Conway-Campbell B.L., McKenna M.A., Pooley J.R., Johnson T.A., Voss T.C., Lightman S.L., Hager G.L. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol. 2009;11(9):1093-1102. DOI: 10.1038/ncb1922
49. Thompson E.B. The structure of the human glucocorticoid receptor and its gene. J. Steroid Biochem. 1987;27:105-8. DOI: 0.1016/00224731(87)90300-1
50. Truss M., Beato M. Steroid hormone receptors: interaction with deoxyribo-nucleic acids and transcription factors. Endocrine Rev. 1993;14:459-478. DOI: 10.1210/er.14.4.459
51. Verma S., Vanryzin C., Sinaii N., Kim M.S., Nieman L.K., Ravindran S., Calis K.A., Arlt W., Ross R.J., Merke D.P. A pharmacokinetic and pharmacodynamic study of delayedand extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin. Endocrinol. 2010;72(4):441-7. DOI: 10.1111/j.1365-2265.2009.03636.x
52. Wang Z., Malone M.H., He H., McColl K.S., Distelhorst C.W. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J. Biol. Chem. 2003;278(26):23861-72386. DOI: 10.1074/jbc.M301843200
53. Walker D., Htun H., Hager G.L. Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. Methods. 1999;19(3):386-393. DOI: 10.1006/meth.1999.0874
54. Wallberg A.E., Flinn E.M., Gustafsson J.A., Wright A.P. Recruitment of chromatin remodelling factors during gene activation via the glucocorticoid receptor N-terminal domain. Biochem. Soc. Trans. 2000;28(4):410-414.
55. Wrange O., Carlstedt-Duke J., Gustaffson J.-A. Purification of the glucocorticoid receptor from rat liver cytosol. J. Biol. Chem. 1979;254(18): 9284-9290.
56. Young E.A., Carlson N.E., Brown M.B. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology. 2001;25(2):267-276. DOI: 10.1016/S0893-133X(00)00236-0
57. Young E.A., Abelson J., Lightman S.L. Cortisol pulsatility and its role in stress regulation and health. Front. Neuroendocrinol. 2004;25(2): 69-76. DOI: 10.1016/j.yfrne.2004.07.001
